It is reasonable to deduce that eNOS activity is downregulated by the diabetes-induced oxidative stress, which is reversed by the antioxidative action of luteolin during reperfusion to reduce further the cardiac I/R oxidative injury. This evidence concerns the gene NOS3 and diabetes mellitus.